Literature DB >> 12482158

Health-related quality of life and healthcare resource utilization by COPD patients: a comparison of three instruments.

R Desikan1, H L Mason, M T Rupp, M Skehan.   

Abstract

The aim of this study was to compare the SF-36 and two disease-specific instruments--St. George's Respiratory Questionnaire (SGRQ) and Chronic Respiratory Disease Questionnaire (CRDQ) among chronic obstructive pulmonary disease (COPD) patients using healthcare utilization data. The three instruments were administered twice by telephone interview to 40 COPD patients separated by a 3-month interval. Healthcare utilization data were obtained for the 3 months immediately prior to each administration. Reliabilities for sub-scales on the three instruments ranged from 0.70 to 0.90 for the SF-36, from 0.78 to 0.85 for the SGRQ, and from 0.64 to 0.91 for the CRDQ. In general, the study sample had poor physical health, and somewhat better mental health. None of the demographic variables were significantly associated with either health status or utilization. Among the three instruments, the SF-36 explained the most variance in healthcare utilization. The aggregate scores such as the summary scores of the SF-36 and the total score of the SGRQ did not perform as well as the individual sub-scales of the respective instruments in explaining the variation in utilization. The conclusion that the SF-36 provides the best association to healthcare utilization data from among the three instruments studied should be interpreted with caution given the small sample size and relatively brief duration of the study.

Entities:  

Mesh:

Year:  2002        PMID: 12482158     DOI: 10.1023/a:1020836719321

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  27 in total

1.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

2.  Measurement of health-related quality of life in chronic airflow limitation.

Authors:  G Guyatt
Journal:  Monaldi Arch Chest Dis       Date:  1993-10

Review 3.  Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease.

Authors:  J R Curtis; R A Deyo; L D Hudson
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

4.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

5.  Measuring health status in chronic airflow limitation.

Authors:  G Guyatt
Journal:  Eur Respir J       Date:  1988-06       Impact factor: 16.671

6.  Why quality of life measures should be used in the treatment of patients with respiratory illness.

Authors:  P W Jones; F H Quirk; C M Baveystock
Journal:  Monaldi Arch Chest Dis       Date:  1994-02

7.  Life quality of patients with chronic obstructive pulmonary disease.

Authors:  A J McSweeny; I Grant; R K Heaton; K M Adams; R M Timms
Journal:  Arch Intern Med       Date:  1982-03

8.  Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease.

Authors:  P J Wijkstra; E M Ten Vergert; R van Altena; V Otten; J Kraan; D S Postma; G H Koëter
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

9.  Reliability and validity of the chronic respiratory questionnaire (CRQ).

Authors:  P J Wijkstra; E M TenVergert; R Van Altena; V Otten; D S Postma; J Kraan; G H Koëter
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

10.  Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD.

Authors:  D A Mahler; J I Mackowiak
Journal:  Chest       Date:  1995-06       Impact factor: 9.410

View more
  9 in total

1.  Insomnia in patients with COPD.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Pooja Budhiraja; Michael P Habib; Christopher Wendel; Stuart F Quan
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

2.  Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma.

Authors:  Bernd Brüggenjürgen; Dagmar Selim; Peter Kardos; Kai Richter; Claus Vogelmeier; Stephanie Roll; Wolfgang Meyer-Sabellek; Roland Buhl; Stefan N Willich
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Patient-reported outcome measures for chronic obstructive pulmonary disease : the exclusion of people with low literacy skills and learning disabilities.

Authors:  Deepa Jahagirdar; Thilo Kroll; Karen Ritchie; Sally Wyke
Journal:  Patient       Date:  2013       Impact factor: 3.883

4.  Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease.

Authors:  Linda Timm Wagner; Charlotte A Kenreigh
Journal:  Core Evid       Date:  2005-03-31

Review 5.  Combining scores from different patient reported outcome measures in meta-analyses: when is it justified?

Authors:  Milo A Puhan; Irene Soesilo; Gordon H Guyatt; Holger J Schünemann
Journal:  Health Qual Life Outcomes       Date:  2006-12-07       Impact factor: 3.186

6.  Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD.

Authors:  Gui-Yun Jiang; Qun Li; Yun-Xiang Lv
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-12-20

7.  The Covid Impact to Public Healthcare Utilization Among Urban Low-Income Subsidized Community in Klang Valley Malaysia.

Authors:  Sharifah Zawani Syed Ahmad Yunus; Sharifa Ezat Wan Puteh; Adliah Mhd Ali; Faiz Daud
Journal:  Health Serv Res Manag Epidemiol       Date:  2021-03-17

8.  Validation of the clinical COPD Questionnaire (CCQ) in primary care.

Authors:  Björn Ställberg; Mika Nokela; Per-Olof Ehrs; Paul Hjemdal; Eva Wikström Jonsson
Journal:  Health Qual Life Outcomes       Date:  2009-03-25       Impact factor: 3.186

9.  Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD.

Authors:  Yvette R B M van Gestel; Sanne E Hoeks; Don D Sin; Henk Stam; Frans W Mertens; Jeroen J Bax; Ron T van Domburg; Don Poldermans
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.